Jamil Khurram
Galectin Therapeutics Inc. · Chief Medical Officer
Jamil Khurram is listed in filings as Chief Medical Officer at Galectin Therapeutics Inc.. This profile follows SEC Form 4 activity through May 28, 2026, including sale activity. Recent filings connect the profile to Galectin Therapeutics Inc. (GALT). The current snapshot covers public activity from Aug 5, 2024 to May 28, 2026. Reported amounts are shown as $1.8K to $197.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $78k21.4k shares | SellJan 6, 2026 | $3.65 | $4.18 | |
| $99k25.5k shares | SellJan 5, 2026 | $3.90 | $4.18 | |
| $55k13.1k shares | SellJan 2, 2026 | $4.20 | $4.18 | |
| $33k8.1k shares | SellDec 31, 2025 | $4.07 | $4.18 | |
| $60k8.5k shares | SellDec 17, 2025 | $7.04 | $4.18 | |
| $227k41.5k shares | SellNov 13, 2025 | $5.47 | $4.18 | |
| $89k16.3k shares | SellNov 13, 2025 | $5.47 | $4.18 | |
| $12k13.7k shares | SellDec 23, 2024 | $0.8821 | $4.18 |